Literature DB >> 8806267

Lactate dehydrogenase should be used as marker in testicular tumours.

O Hughes, M Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8806267      PMCID： PMC2352026          DOI： 10.1136/bmj.313.7057.625b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Serum markers in germ cell neoplasms.

Authors:  N L Bartlett; F S Freiha; F M Torti
Journal:  Hematol Oncol Clin North Am       Date:  1991-12       Impact factor: 3.722

Review 2.  ABC of urology. Urological malignancy--III: Renal and testicular carcinoma.

Authors:  C Dawson; H Whitfield
Journal:  BMJ       Date:  1996-05-04

Review 3.  The use of tumor markers in germ cell malignancies.

Authors:  G J Bosl; R S Chaganti
Journal:  Hematol Oncol Clin North Am       Date:  1994-06       Impact factor: 3.722

4.  Prognostic factors for favorable outcome in disseminated germ cell tumors.

Authors:  R Birch; S Williams; A Cone; L Einhorn; P Roark; S Turner; F A Greco
Journal:  J Clin Oncol       Date:  1986-03       Impact factor: 44.544

5.  Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.

Authors:  D G Skinner; P T Scardino
Journal:  J Urol       Date:  1980-03       Impact factor: 7.450
  5 in total
  2 in total

Review 1.  Circulating Biomarkers for Therapeutic Monitoring of Anti-cancer Agents.

Authors:  Helena J Janse van Rensburg; Pavlina Spiliopoulou; Lillian L Siu
Journal:  Oncologist       Date:  2022-05-06       Impact factor: 5.837

2.  The usefulness of lactate dehydrogenase measurements in current oncological practice.

Authors:  Agata Forkasiewicz; Maja Dorociak; Kamilla Stach; Piotr Szelachowski; Renata Tabola; Katarzyna Augoff
Journal:  Cell Mol Biol Lett       Date:  2020-06-09       Impact factor: 5.787
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.